Center for Drug Safety & Effectiveness
Drawing on the combined expertise of the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins School of Medicine, the Center for Drug Safety and Effectiveness serves as a nexus for individuals at Johns Hopkins who are involved in research, education, clinical programs and public service to improve prescription drug use and pharmaceutical policy in the United States and around the world. The unparalleled knowledge base of the Center’s core faculty reflects a diversity of fields, ranging from pharmacovigilance to regulatory policy.
News
- Drug overdoses probed in USC student deaths, pointing to ‘twin epidemics’
Los Angeles Times, November 14, 2019 - FDA too slow in assessing cancer link to blood pressure drugs, watchdog says
CBS News, October 10, 2019 - Opioid epidemic: Fight addiction and chronic pain together to save lives
USA Today, April 25, 2019 - Older Americans are awash in antibiotics
New York Times, March 15, 2019 - Does science show that unprescribed buprenorphine saves lives?
PolitiFact, April 7, 2019 - Misuse of Rx opioids linked to other high-risk behaviors
Physician’s Weekly, February 8, 2019 - Common diabetes drug found safe for most diabetics with kidney disease
ScienceDaily, June 5, 2018 - As Opioid Prescriptions Fall, Prescriptions for Drugs to Treat Addiction Rise
New York Times, April 19, 2018 - Many People Taking Antidepressants Discover They Cannot Quit
New York Times, April 7, 2018 - Nearly 1 In 3 Recent FDA Drug Approvals Followed by Major Safety Actions
Scientific American, May 9, 2017 - Opioid Prescriptions Fall after 2010 Peak, CDC Report Finds
New York Times, July 6, 2017 - The Unnecessary Risk with Over-the-Counter Drugs
Politico, July 24, 2017
Welcome
The Center for Drug Safety and Effectiveness seeks to improve the safe and effective use of medications through a fourfold mission – training, research, patient care and public service – towards best medication practices.
Congratulations
Jodi Segal, MD, MPH, Center Co-Director, was recently elected to be a Fellow of the International Society of Pharmacoepidemiology (a FISPE) in recognition of her contributions to the field and to the Society.
Learn MoreNew Course Offering
Study Design and Analysis for Causal Inference With Time-Varying Exposures (340.776.01) is being offered during the 4th Term (Course Instructor: John W. Jackson).
Learn MoreTraining
The Center for Drug Safety and Effectiveness is training the next generation of leaders in pharmacoepidemiology and drug safety. The Center supports a diverse group of trainees, from masters' and doctoral students to clinical residents, fellows and junior faculty.
Learn More